QIM
MDGL icon

Quantitative Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quantitative Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-569
Closed -$260K – 492
2025
Q3 		$260K Buy
+569
New +$212K 0.04% 295
2023
Q2 		– Sell
-2,070
Closed -$501K – 321
2023
Q1 		$501K Buy
+2,070
New +$564K 0.11% 157
2020
Q4 		– Sell
-6,662
Closed -$790K – 546
2020
Q3 		$790K Sell
6,662
-2,680
-29% -$291K 0.07% 203
2020
Q2 		$1.06M Buy
+9,342
New +$919K 0.11% 196

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantitative Investment Management's MDGL Position: Q4 2025 in Review

Quantitative Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2025, closing a stake of 569 shares — an estimated $260K sold.

Quantitative Investment Management first reported a position in MDGL in Q2 2020 and held it in 4 quarters. The position peaked at $1.06M in Q2 2020. 387 funds tracked by Wall St. Rank hold MDGL as of Q4 2025.

  • Quantitative Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quantitative Investment Management sold 569 Madrigal Pharmaceuticals shares in Q4 2025, an estimated $260K.
  • Quantitative Investment Management first reported a position in Madrigal Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Quantitative Investment Management's Madrigal Pharmaceuticals position peaked at $1.06M in Q2 2020.
  • 387 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2025.

Based on Quantitative Investment Management's 13F filing for Q4 2025, filed 17 Feb 2026.